Benjamin Edwards Inc’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.06M	Buy	82,563 +3,363	+4%	+$42.8K	0.01%	741
2025 Q4	$712K	Buy	79,200 +14,350	+22%	+$198K	0.01%	828
2025 Q3	$1.12M	Buy	64,850 +1,816	+3%	+$22.4K	0.01%	648
2025 Q2	$591K	Buy	63,034 +1,126	+2%	+$9.25K	0.01%	799
2025 Q1	$440K	Sell	61,908 -2,157	-3%	-$21.8K	0.01%	826
2024 Q4	$747K	Buy	64,065 +6,396	+11%	+$99.8K	0.01%	706
2024 Q3	$1.18M	Buy	57,669 +57,253	+13,763%	+$1.32M	0.02%	551
2024 Q2	$9K	Sell	416 -146	-26%	-$3.48K	﹤0.01%	624
2024 Q1	$15K	Buy	562 +35	+7%	+$972	﹤0.01%	605
2023 Q4	$16K	Sell	527 -317	-38%	-$9.11K	﹤0.01%	555
2023 Q3	$27K	Buy	844 +78	+10%	+$3.03K	0.01%	517
2023 Q2	$31K	Buy	766 +18	+2%	+$730	0.01%	507
2023 Q1	$28K	Buy	748 +38	+5%	+$1.49K	0.01%	512
2022 Q4	$25K	Buy	710 +141	+25%	+$6.7K	0.01%	482
2022 Q3	$32K	Sell	569 -44	-7%	-$2.73K	0.01%	454
2022 Q2	$32K	Buy	613 +6	+1%	+$305	0.01%	471
2022 Q1	$44K	Sell	607 -81	-12%	-$6.86K	0.01%	467
2021 Q4	$81K	Buy	688 +36	+6%	+$4.51K	0.03%	372
2021 Q3	$87K	Sell	652 -198	-23%	-$30K	0.05%	246
2021 Q2	$138K	Sell	850 -443	-34%	-$34.5K	0.09%	188
2021 Q1	$104K	Sell	1,293 -8	-0.6%	-$537	0.08%	198
2020 Q4	$71K	Sell	1,301 -593	-31%	-$21.5K	0.06%	216
2020 Q3	$38K	Buy	1,894 +77	+4%	+$1.61K	0.03%	242
2020 Q2	$38K	Hold	1,817	–	–	0.03%	223
2020 Q1	$22K	Sell	1,817 -61	-3%	-$822	0.02%	234
2019 Q4	$28K	Buy	1,878 +223	+13%	+$3.1K	0.06%	150
2019 Q3	$22K	Sell	1,655 -36	-2%	-$574	0.05%	162
2019 Q2	$28K	Buy	1,691 +640	+61%	+$10.1K	0.07%	145
2019 Q1	$18K	Buy	+1,051	New	+$15.7K	0.09%	169